Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-24T05:16:23.168Z Has data issue: false hasContentIssue false
  • English
  • Français

Improving the physiological relevance of drug testing for drug-loaded nanoparticles using 3D tumor cell cultures

Published online by Cambridge University Press:  10 July 2019

Priya Nimbalkar ,
Peter Tabada ,
Anuja Bokare ,
Jeffrey Chung ,
Marzieh Mousavi ,
Melinda Simon  and
Folarin Erogbogbo
Priya Nimbalkar
Affiliation:
Department of Biomedical, Chemical, and Materials Engineering, San Jose State University, 1 Washington Square, San Jose, CA 95112, USA
Peter Tabada
Affiliation:
Department of Biomedical, Chemical, and Materials Engineering, San Jose State University, 1 Washington Square, San Jose, CA 95112, USA
Anuja Bokare
Affiliation:
Department of Biomedical, Chemical, and Materials Engineering, San Jose State University, 1 Washington Square, San Jose, CA 95112, USA
Jeffrey Chung
Affiliation:
Department of Biomedical, Chemical, and Materials Engineering, San Jose State University, 1 Washington Square, San Jose, CA 95112, USA
Marzieh Mousavi
Affiliation:
Department of Biomedical, Chemical, and Materials Engineering, San Jose State University, 1 Washington Square, San Jose, CA 95112, USA
Melinda Simon
Affiliation:
Department of Biomedical, Chemical, and Materials Engineering, San Jose State University, 1 Washington Square, San Jose, CA 95112, USA
Folarin Erogbogbo*
Affiliation:
Department of Biomedical, Chemical, and Materials Engineering, San Jose State University, 1 Washington Square, San Jose, CA 95112, USA
*
Address all correspondence to Folarin Erogbogbo at folarin.erogbogbo@sjsu.edu
Get access

Abstract

Nanoparticle-mediated drug delivery has the potential to overcome several limitations of cancer chemotherapy. Lipid polymer hybrid nanoparticles (LPHNPs) have been demonstrated to exhibit superior cellular delivery efficacy. Hence, doxorubicin (a chemotherapeutic drug)-loaded LPHNPs have been synthesized by three-dimensional (3D)-printed herringbone-patterned multi-inlet vortex mixer. This method offers rapid and efficient mixing of reactants yielding controllable and reproducible synthesis of LPHNPs. The cytotoxicity of LPHNPs is tested using two-dimensional (2D) and 3D microenvironments. Results obtained from 3D cell cultures showed major differences in cytotoxicity in comparison with 2D cultures. These results have broad implications in predicting in vitro LPHNP toxicology.

Type
Research Letters
Information
MRS Communications , Volume 9 , Issue 3 , September 2019 , pp. 1053 - 1059
Copyright
Copyright © Materials Research Society 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hood, A.F.: Cutaneous side effects of cancer chemotherapy. Med. Clin. North Am. 1, 187–209 (1986).Google Scholar
2.Chaudhary, P.M. and Roninson, I.B.: Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 8, 632–639 (1993).Google Scholar
3.Hesketh, P.J.: Chemotherapy-induced nausea and vomiting. N. Engl. J. Med. 23, 2482–2494 (2008).Google Scholar
4.Cho, K., Wang, X., Nie, S., Chen, Z., and Shin, D.M.: Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 5, 1310–1316 (2008).Google Scholar
5.Brigger, I., Dubernet, C., and Couvreur, P.: Nanoparticles in cancer therapy and diagnosis. Adv. Drug. Deliv. Rev. 64, 24–36 (2012).Google Scholar
6.Sahoo, S.K., Misra, R., and Parveen, S.: Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. In Nanomedicine in Cancer, edited by Balogh, L.P. (Pan Stanford, 2017), pp. 73–124. https://www.taylorfrancis.com/books/e/9781315114361/chapters/10.1201/b22358-3.Google Scholar
7.Yih, T.C. and Al-Fandi, M.: Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 6, 1184–1190 (2006).Google Scholar
8.Malam, Y., Loizidou, M., and Seifalian, A.M.: Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol. Sci. 11, 592–599 (2009).Google Scholar
9.Reis, C.P., Neufeld, R.J., and Veiga, F.: Preparation of drug-loaded polymeric nanoparticles. In Nanomedicine in Cancer, edited by Balogh, L.P. (Pan Stanford, 2017), pp. 197–240. https://www.taylorfrancis.com/books/e/9781315114361/chapters/10.1201/b22358-7.Google Scholar
10.Sun, J., Zhang, L., Wang, J., Feng, Q., Liu, D., Yin, Q., Xu, D., Wei, Y., Ding, B., Shi, X., and Jiang, X.: Tunable rigidity of (polymeric core)–(lipid shell) nanoparticles for regulated cellular uptake. Adv. Mater. 8, 1402–1407 (2015).Google Scholar
11.Hadinoto, K., Sundaresan, A., and Cheow, W.S.: Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur. J. Pharm. Biopharm. 3, 427–443 (2013).Google Scholar
12.Ramasamy, T., Tran, T.H., Choi, J.Y., Cho, H.J., Kim, J.H., Yong, C.S., Choi, H.G., and Kim, J.O.: Layer-by-layer coated lipid–polymer hybrid nanoparticles designed for use in anticancer drug delivery. Carbohydr. Polym. 102, 653–661 (2014).Google Scholar
13.Cheow, W.S. and Hadinoto, K.: Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles. Colloids Surf. B Biointerfaces 2, 214–220 (2011).Google Scholar
14.Thorn, C.F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T.E., and Altman, R.B.: Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet. Genomics 7, 440–446 (2011).Google Scholar
15.Prasad, P.N.: Introduction to Nanomedicine and Nanobioengineering (John Wiley & Sons, Hoboken, NJ, 2012).Google Scholar
16.Bose, R.J.C., Ravikumar, R., Karuppagounder, V., Bennet, D., Rangasamy, S., and Thandavarayan, R.A.: Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges. Drug Discov. Today 8, 1258–1265 (2017).Google Scholar
17.Valencia, P.M., Basto, P.A., Zhang, L., Rhee, M., Laanger, R., Farokhzad, F.C., and Karnik, R.: Single-step assembly of homogenous lipid−polymeric and lipid−quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano 3, 1671–1679 (2010).Google Scholar
18.Idrees, A., Chiono, V., Ciardelli, G., Shah, S., Viebahn, R., Zhang, X., and Salbar, J.: Validation of in vitro assays in three-dimensional human dermal constructs. Int. J. Artif. Organs 11, 779–788 (2018).Google Scholar
19.Le, L., Bokare, A., and Erogbogbo, F.: Hand powered, cost effective, 3D printed nanoparticle synthesizer: effects of polymer end caps, drugs, and solvents on lipid polymer hybrid nanoparticles. Mater. Res. Express 2, 025403 (2018).Google Scholar
20.Kim, T., Doh, I., and Cho, Y.-H.: On-chip three-dimensional tumor spheroid formation and pump-less perfusion culture using gravity-driven cell aggregation and balanced droplet dispensing. Biomicrofluidics 3, 034107 (2012).Google Scholar
21.Shi, Y., Fox, R.O., and Olsen, M.G.: Micromixing visualization and quantification in a microscale multi-inlet vortex nanoprecipitation reactor using confocal-based reactive micro laser-induced fluorescence. Biomicrofluidics 4, 044102 (2014).Google Scholar
22.Liu, Z., Ramezani, M., Fox, R.O., Hill, J.C., and Olsen, M.G.: Flow characteristics in a scaled-up multi-inlet vortex nanoprecipitation reactor. Ind. Eng. Chem. Res. 16, 4512–4525 (2015).Google Scholar
23.Williams, M.S., Longmuir, K.J., and Yager, P.: A practical guide to the staggered herringbone mixer. Lab Chip 8, 1121–1129 (2008).Google Scholar
24.Geraghty, R.J., Capes-Davis, A., Davis, J.M., Downward, J., Freshney, R.I., Knezevic, I., Lovel-Badge, R., Masters, J.R.W., Meredith, J., Stacy, G.N., Thraves, P., and Vias, M.: Guidelines for the use of cell lines in biomedical research. Br. J. Cancer 6, 1021–1046 (2014).Google Scholar
25.Bigdeli, S., Dettloff, R.O., Frank, C.W., Davis, R.W., and Crosby, L.D.: A simple method for encapsulating single cells in alginate microspheres allows for direct PCR and whole genome amplification. PLoS One 2, e0117738 (2015).Google Scholar
26.Xu, Z., Lu, C., Riordon, J., Sinton, D., and Moffitt, M.G.: Microfluidic manufacturing of polymeric nanoparticles: comparing flow control of multiscale structure in single-phase staggered herringbone and two-phase reactors. Langmuir 48, 12781–12789.Google Scholar
27.Edmondson, R., Broglie, J.J., Adcock, A.F., and Yang, L.: Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev. Technol. 4, 207–218 (2014).Google Scholar
28.Lovitt, C.J., Shelper, T.B., and Avery, V.M.: Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer 1, 41 (2018). doi:10.1186/s12885-013953-6Google Scholar
29.Gong, X., Lin, C., Cheng, J., Su, J., Zhao, H., Liu, T., Wen, X., and Zhao, P.: Generation of multicellular tumor spheroids with microwell-based agarose scaffolds for drug testing. PLoS One 6, e0130348 (2015).Google Scholar
30.Olive, P.L. and Durand, R.E.: Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev. 2, 121–138 (1994).Google Scholar